OpiCalc

989 Clinical Tools

ALBI Grade (Liver)ASTCT Grading ATA Thyroid Risk BCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPI CML ELTS Score CNS-IPI CTCAE v5.0 Calvert Formula DIPSS-Plus (Myelofibrosis)Deauville Score EAU NMIBC Risk ECOG Performance Status ELN 2022 Risk (AML)ELN CML Milestones FIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2 Fleischner 2017 Guidelines Fong Clinical Risk Score HCT-CI (Sorror Score)HPV/p16 Oropharynx IGCCCG Risk (Testicular)IMDC (Heng) Criteria IMWG Myeloma Frailty IPSS-M (Molecular MDS)ISUP Grade Groups Karnofsky Status (KPS)Khorana Score Lugano Classification Lung-RADS v2022 MIPI-b (Biological)MRD Assessment Framework MSI/MMR Interpretation Mayo 20/2/20 (SMM)NCCN Prostate Risk NCCN-IPI (DLBCL)NSCLC GPA Oncotype DX Recurrence Opioid Equianalgesic PD-L1 TPS Interpretation PERCIST 2.0 PREDICT v3.0 Platinum-Free Interval R2-ISS (Revised 2)RANO 2.0 RCB (Residual Cancer Burden)RECIST 1.1 ROMA Score SAVER Score SINS Score SLiM-CRAB Criteria Sedlis/Peters Criteria TNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AML Z0011 Eligibility iRECIST iwCLL 2018 Response mRECIST (HCC)mRENAL Score mrTRG (Rectal MRI)

ATA Thyroid Risk

Head, Neck & CNS

American Thyroid Association recurrence risk framework.

Gross extrathyroidal extension

Distant metastases

Incomplete tumor resection

Microscopic extrathyroidal extension

Aggressive histology

Vascular invasion

Large-volume or multiple nodal metastases

Calculated Interpretation

Low Risk

ATA recurrence risk stratification helps frame RAI and surveillance planning after surgery.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Primary Use

American Thyroid Association recurrence risk framework.

Section 2

Formula & Logic

Clinical Inputs

Gross extrathyroidal extension	Binary clinical feature
Distant metastases	Binary clinical feature
Incomplete tumor resection	Binary clinical feature
Microscopic extrathyroidal extension	Binary clinical feature
Aggressive histology	Binary clinical feature
Vascular invasion	Binary clinical feature
Large-volume or multiple nodal metastases	Binary clinical feature

Section 3

Pearls/Pitfalls

Result Bands

Section 4

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.

Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

Section 5

Evidence Appraisal

Evidence Base

American Thyroid Association recurrence risk framework.

OpiCalc Medical Oncology Module • Head, Neck & CNS. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.

Section 6

Literature

Context

ATA Thyroid Risk is included in the oncology module as a structured decision-support tool for head, neck & cns workflows.

Last Comprehensive Review: 2026

Related Oncology Tools

Fong Clinical Risk Score

Have feedback about this calculator?Let us know.

ATA Thyroid Risk

Head, Neck & CNS

American Thyroid Association recurrence risk framework.

Gross extrathyroidal extension

Distant metastases

Incomplete tumor resection

Microscopic extrathyroidal extension

Aggressive histology

Vascular invasion

Large-volume or multiple nodal metastases

Calculated Interpretation

Low Risk

ATA recurrence risk stratification helps frame RAI and surveillance planning after surgery.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Primary Use

American Thyroid Association recurrence risk framework.

Section 2

Formula & Logic

Clinical Inputs

Gross extrathyroidal extension	Binary clinical feature
Distant metastases	Binary clinical feature
Incomplete tumor resection	Binary clinical feature
Microscopic extrathyroidal extension	Binary clinical feature
Aggressive histology	Binary clinical feature
Vascular invasion	Binary clinical feature
Large-volume or multiple nodal metastases	Binary clinical feature

Section 3

Pearls/Pitfalls

Result Bands

Section 4

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.

Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

Section 5

Evidence Appraisal

Evidence Base

American Thyroid Association recurrence risk framework.

OpiCalc Medical Oncology Module • Head, Neck & CNS. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.

Section 6

Literature

Context

ATA Thyroid Risk is included in the oncology module as a structured decision-support tool for head, neck & cns workflows.

Last Comprehensive Review: 2026

Related Oncology Tools

Fong Clinical Risk Score

Have feedback about this calculator?Let us know.